Sickle cell disease study
EMBARGOED TO 0001 FRIDAY MAY 3 File photo dated 18/01/23 of staff on a NHS hospital ward at Ealing Hospital in London. Around 4,000 people with sickle cell disease in England could benefit from a "life-changing" new treatment after it was given the green light for use in the NHS. Health leaders said that voxelotor, also known as oxbryta and made by Pfizer, will significantly improve quality of life for patients with the condition. Issue date: Friday May 3, 2024.